Effects and mechanisms of extract from Paeonia lactiflora and Astragalus membranaceus on liver fibrosis induced by carbon tetrachloride in rats

Journal of Ethnopharmacology

Volumn 112, Issue 3, 2007, Pages 514-523

  Sun, Wu Yi ^a   Wei, Wei ^a   Wu, Li ^a,b   Gui, Shuang Ying ^a,c   Wang, Hua ^a  

^a ANHUI MEDICAL UNIVERSITY   (China)

^b NANJING UNIVERSITY OF CHINESE MEDICINE   (China)

^c ANHUI UNIVERSITY OF CHINESE MEDICINE   (China)

Author keywords

Astragalus membranaceus; Hepatic stellate cell; Liver fibrosis; Oxidative stress; Paeonia lactiflora; Transforming growth factor 1

Indexed keywords

AMINOTRANSFERASE; ASTRAGALUS MEMBRANACEUS EXTRACT; CARBON TETRACHLORIDE; FREE RADICAL; GLUTATHIONE; HYALURONIC ACID; HYDROXYPROLINE; LAMININ; PAEONIA LACTIFLORA EXTRACT; PAEONIA LACTIFLORA EXTRACT AND ASTRAGALUS MEMBRANACEUS EXTRACT; PLATELET DERIVED GROWTH FACTOR BB; PROCOLLAGEN; PROCOLLAGEN TYPE 3; PROLINE; SUPEROXIDE DISMUTASE; THYMIDINE; TRANSFORMING GROWTH FACTOR BETA1; TRITIUM; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; ASTRAGALUS MEMBRANACEUS; CONTROLLED STUDY; DISEASE MODEL; DRUG EFFECT; DRUG EFFICACY; DRUG MECHANISM; ENZYME ACTIVITY; LIPID PEROXIDATION; LIVER CELL; LIVER FIBROSIS; LIVER PROTECTION; MALE; NONHUMAN; PAEONIA LACTIFLORA; PROTEIN BLOOD LEVEL; RAT; SPRAGUE DAWLEY RAT; STELLATE CELL;

ALANINE TRANSAMINASE; ANIMALS; ASPARTATE AMINOTRANSFERASES; ASTRAGALUS PLANT; CARBON TETRACHLORIDE; CELL PROLIFERATION; COLLAGEN; COLLAGEN TYPE III; DOSE-RESPONSE RELATIONSHIP, DRUG; GLUTATHIONE PEROXIDASE; HEPATOCYTES; HYALURONIC ACID; HYDROXYPROLINE; INJECTIONS, SUBCUTANEOUS; LAMININ; LIPID PEROXIDATION; LIVER CIRRHOSIS, EXPERIMENTAL; MALE; MALONDIALDEHYDE; PAEONIA; PLANT EXTRACTS; RATS; RATS, SPRAGUE-DAWLEY; SUPEROXIDE DISMUTASE; TRANSFORMING GROWTH FACTOR BETA1;

ASTRAGALUS MEMBRANACEUS; PAEONIA LACTIFLORA; RATTUS;

EID: 34347350269     PISSN: 03788741     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jep.2007.04.005     Document Type: Article

References (53)

1. Aboutwerat A., Pemberton P.W., Smith A., Burrows P.C., McMahon R.F., Jain S.K., and Warnes T.W. Oxidant stress is a significant feature of primary biliary cirrhosis. Biochimica et Biophysica Acta 1637 (2003) 142-150
2. Achliya G.S., Wadodkar S.G., and Dorle A.K. Evaluation of hepatoprotective effect of Amalkadi Ghrita against carbon tetrachloride induced hepatic damage in rats. Journal of Ethnopharmacology 90 (2004) 229-232
3. Alpini G., Phillips J.O., Vroman B., and LaRusso N.F. Recent advances in the isolation of liver cells. Hepatology 20 (1994) 494-514
4. Bataller R., and Brenner D.A. Liver fibrosis. The Journal of Clinical Investigation 115 (2005) 209-218
5. Beljaars L., Meijer D.K., and Poelstra K. Targeting hepatic stellate cells for cell-specific treatment of liver fibrosis. Frontiers in Bioscience 7 (2002) e214-e222
6. Benyon R.C., Hovell C.J., Da Gaca M., Jones E.H., Iredale J.P., and Arthur M.J. Progelatinase A is produced and activated by rat hepatic stellate cells and promotes their proliferation. Hepatology 30 (1999) 977-986
7. Cabre M., Camps J., Paternain J.L., Ferre N., and Joven J. Time-course of changes in hepatic lipid peroxidation and glutathione metabolism in rats with carbon tetrachloride-induced cirrhosis. Clinical and Experimental Pharmacology & Physiology 27 (2000) 694-699
8. Casini A., Pinzani M., Milani S., Grappone C., Galli G., Jezequel A.M., Schuppan D., Rotella C.M., and Surrenti C. Regulation of extracellular matrix synthesis by transforming growth factor beta 1 in human fat-storing cells. Gastroenterology 105 (1993) 245-253
9. Cheng P., Liu S.X., Sun J.J., Wang Z.H., Xu Z.D., and Peng C.H. Relationship between antifibrotic effect of Astragalus membranaceus on liver fibrosis and transforming growth factor beta1 or interferon gamma. Clinical Journal of Medical Officer 28 (2000) 22-23
10. Chor S.Y., Hui A.Y., To K.F., Chan K.K., Go Y.Y., Chan H.L., Leung W.K., and Sung J.J. Anti-proliferative and pro-apoptotic effects of herbal medicine on hepatic stellate cell. Journal of Ethnopharmacology 100 (2005) 180-186
11. Dai L.M., Chen M.Z., and Xu S.Y. Protective effects of total glucocides of paeony on experimental hepatitis. Zhongguo Yaolixue Tongbao 9 (1993) 449-453
12. Drewa G., Krzyzynska-Malinowska E., Wozniak A., Protas-Drozd F., Mila-Kierzenkowska C., Rozwodowska M., Kowaliszyn B., and Czajkowski R. Activity of superoxide dismutase and catalase and the level of lipid peroxidation products reactive with TBA in patients with psoriasis. Medical Science Monitor 8 (2002) BR338-BR343
13. Fowell A.J., and Iredale J.P. Emerging therapies for liver fibrosis. Digestive Diseases 24 (2006) 174-183
14. Friedman S.L. Stellate cells: a moving target in hepatic fibrogenesis. Hepatology 40 (2004) 1041-1043
15. Friedman S.L., and Roll F.J. Isolation and culture of hepatic lipocytes, Kupffer cells, and sinusoidal endothelial cells by density gradient centrifugation with Stractan. Analytical Biochemistry 161 (1987) 207-218
16. Gebhardt R. Oxidative stress, plant-derived antioxidants and liver fibrosis. Planta Medica 68 (2002) 289-296
17. Gressner A.M., and Weiskirchen R. Modern pathogenetic concepts of liver fibrosis suggest stellate cells and TGF-beta as major players and therapeutic targets. Journal of Cellular and Molecular Medicine 10 (2006) 76-99
18. Gressner A.M., Weiskirchen R., Breitkopf K., and Dooley S. Roles of TGF-beta in hepatic fibrosis. Frontiers in Bioscience 7 (2002) d793-d807
19. 4-induced cirrhosis: protective role of adenosine administration. Hepatology 26 (1997) 1100-1110
20. Inao M., Mochida S., Matsui A., Eguchi Y., Yulutuz Y., Wang Y., Naiki K., Kakinuma T., Fujimori K., Nagoshi S., and Fujiwara K. Japanese herbal medicine Inchin-ko-to as a therapeutic drug for liver fibrosis. Journal of Hepatology 41 (2004) 584-591
21. Iredale J.P., Benyon R.C., Pickering J., McCullen M., Northrop M., Pawley S., Hovell C., and Arthur M.J. Mechanisms of spontaneous resolution of rat liver fibrosis. Hepatic stellate cell apoptosis and reduced hepatic expression of metalloproteinase inhibitors. The Journal of Clinical Investigation 102 (1998) 538-549
22. Lee K.S., Buck M., Houglum K., and Chojkier M. Activation of hepatic stellate cells by TGF alpha and collagen type I is mediated by oxidative stress through c-myb expression. The Journal of Clinical Investigation 96 (1995) 2461-2468
23. Lee Y.S., Han O.K., Park C.W., Seong I.S., Shin S.W., Yang C.H., Jeon T.W., Lee E.S., Kim K.J., Kim S.H., Wang K.Y., and Kim H.J. Immunomodulatory effects of aqueous-extracted Astragali radix in methotrexatetreated mouse spleen cells. Journal of Ethnopharmacology 84 (2003) 193-198
24. Li C., Luo J., Li L., Cheng M., Huang N., Liu J., and Waalkes M.P. The collagenolytic effects of the traditional Chinese medicine preparation, Han-Dan-Gan-Le, contribute to reversal of chemical-induced liver fibrosis in rats. Life Sciences 72 (2003) 1563-1571
25. Loguercio C., and Federico A. Oxidative stress in viral and alcoholic hepatitis. Free Radical Biology & Medicine 34 (2003) 1-10
26. Matsuoka M., Pham N.T., and Tsukamoto H. Differential effects of interleukin-1 alpha, tumor necrosis factor alpha, and transforming growth factor beta 1 on cell proliferation and collagen formation by cultured fat-storing cells. Liver 9 (1989) 71-78
27. Matsuoka M., and Tsukamoto H. Stimulation of hepatic lipocyte collagen production by Kupffer cell-derived transforming growth factor beta: implication for a pathogenetic role in alcoholic liver fibrogenesis. Hepatology 11 (1990) 599-605
28. Ma X.Q., Shi Q., and Duan J.A. Chemical analysis of Radix Astragali (Huangqi) in China: a comparison with its adulterants and seasonal variations. Journal of Agriculture Food Chemistry 50 (2002) 4861-4866
29. Mitchell A.D., and Taylor I.E. The spectrophotometric determination of hydroxyproline: an analytical investigation. The Analyst 95 (1970) 1003-1011
30. Mourelle M., Villalon C., and Amezcua J.L. Protective effect of colchicine on acute liver damage induced by carbon tetrachloride. Journal of Hepatology 6 (1988) 337-342
31. Nikolaidis N., Kountouras J., Giouleme O., Tzarou V., Chatzizisi O., Patsiaoura K., Papageorgiou A., Leontsini M., Eugenidis N., and Zamboulis C. Colchicine treatment of liver fibrosis. Hepatogastroenterology 53 (2006) 281-285
32. Nishiyama N., Wang Y., and Saito H. Beneficial effects of S-113m, a novel herbal prescription, on learning impairment model in mice. Biological Pharmaceutical Bulletin 18 (1995) 1498-1503
33. Nissen N.N., and Martin P. Hepatocellular carcinoma: the high-risk patient. Journal of Clinical Gastroenterology 35 (2002) S79-S85
34. Oh W.Y., Pyo S., Lee K.R., Lee B.K., Shin D.H., Cho S.I., and Lee S.M. Effect of Holotrichia diomphalia larvae on liver fibrosis and hepatotoxicity in rats. Journal of Ethnopharmacology 87 (2003) 175-180
35. Okita K., Sakaida I., and Hino K. Current strategies for chemoprevention of hepatocellular carcinoma. Oncology 62 (2002) 24-28
36. Pinzani M. PDGF and signal transduction in hepatic stellate cells. Frontiers in Bioscience 7 (2002) d1720-d1726
37. Pinzani M., Gesualdo L., Sabbah G.M., and Abboud H.E. Effects of platelet-derived growth factor and other polypeptide mitogens on DNA synthesis and growth of cultured rat liver fat-storing cells. The Journal of Clinical Investigation 84 (1989) 1786-1793
38. Pinzani M., and Rombouts K. Liver fibrosis: from the bench to clinical targets. Digestive and Lliver Disease 36 (2004) 231-242
39. Poli G. Pathogenesis of liver fibrosis: role of oxidative stress. Molecular Aspects of Medicine 21 (2000) 49-98
40. Poo J.L., Feldmann G., Moreau A., Gaudin C., and Lebrec D. Early colchicine administration reduces hepatic fibrosis and portal hypertension in rats with bile duct ligation. Journal of Hepatology 19 (1993) 90-94
41. Rachfal A.W., and Brigstock D.R. Connective tissue growth factor (CTGF/CCN2) in hepatic fibrosis. Hepatology Research 26 (2003) 1-9
42. Reeves H.L., and Friedman S.L. Activation of hepatic stellate cells-a key issue in liver fibrosis. Frontiers in Bioscience 7 (2002) d808-d826
43. Schuppan D., Jia J.D., Brinkhaus B., and Hahn E.G. Herbal products for liver diseases: a therapeutic challenge for the new millennium. Hepatology 30 (1999) 1099-1104
44. Shek F.W., and Benyon R.C. How can transforming growth factor beta be targeted usefully to combat liver fibrosis?. European Journal of Gastroenterology & Hepatology 16 (2004) 123-126
45. Shimizu I., Ma Y.R., Mizobuchi Y., Liu F., Miura T., Nakai Y., Yasuda M., Shiba M., Horie T., Amagaya S., Kawada N., Hori H., and Ito S. Effects of Sho-saiko-to, a Japanese herbal medicine, on hepatic fibrosis in rats. Hepatology 29 (1999) 149-160
46. Sugawara H., Ueno T., Torimura T., Inuzuka S., and Tanikawa K. Inhibitory effect of OPC-15161, a component of fungus Thielavia minor, on proliferation and extracellular matrix production of rat cultured hepatic stellate cells. Journal of Cellular Physiology 174 (1998) 398-406
47. Tsukada S., Parsons C.J., and Rippe R.A. Mechanisms of liver fibrosis. Clinica Chimica Acta 364 (2006) 33-60
48. Wang H., Wei W., Wang N.P., Wu C.Y., Yan S.X., Yue L., Zhang L.L., and Xu S.Y. Effects of total glucosides of peony on immunological hepatic fibrosis in rats. World Journal of Gastroenterology 11 (2005) 2124-2129
49. Wasser S., and Tan C.E. Experimental models of hepatic fibrosis in the rat. Annals of the Academy of Medicine 28 (1999) 109-111
50. Wu L., Wei W., Gui S.Y., and Sun W.Y. Effects and mechanisms of Shaoqiduogan on mice with chemical liver injury. China Journal of Chinese Materia Medica 31 (2006) 14-17
51. Wu Q., Yang Y., Xue S.L., Zhang X.Q., Zhou Y.H., and Chen M.Z. Effect of astragalosides on proliferation and collagen production of hepatic stellate cells in vitro. Chinese Pharmacological Bulletin 19 (2003) 892-895
52. Yang Y., Nemoto E.M., Harvey S.A., Subbotin V.M., and Gandhi C.R. Increased hepatic platelet activating factor (PAF) and PAF receptors in carbon tetrachloride induced liver cirrhosis. Gut 53 (2004) 877-883
53. Zhang X.Y., Wang J.H., and Li X. A study on the chemical constituents of Paeonia lactiflora Pall. Journal of Shenyang Pharmaceutical University 18 (2001) 30-32